ALHC

Alignment Healthcare's stock price experienced significant declines over the past six months, losing approximately 65% from early July to October 9, 2026, with a 43% drop in the 30 days leading up to October 9, 2026. Key events impacting the stock include mounting medical cost headwinds and increased investments, particularly impacting fiscal Q3 2026 due to acute hospital billing and skilled nursing facility challenges. The company also faced whistleblower allegations and legal investigations concerning financial manipulation. On October 8, 2026, the Centers for Medicare & Medicaid Services (CMS) released its 2027 Star Ratings, where its critical California H3815 HMO contract received a 3.5-Star rating, jeopardizing bonus payments and potentially leading to enrollment decline and margin pressure for 2027, causing a 16% stock decline. These events led to analyst price-target cuts and negative market sentiment. Despite beating revenue and EPS estimates for Q2 2026, shares declined 20.2% the day after the earnings report on July 30, 2026.